Diabetes 53:1643-1648, 2004
© 2004 by the American Diabetes Association, Inc.
Interleukin-6 Is a Novel Factor Mediating Glucose Homeostasis During Skeletal Muscle Contraction
Mark A. Febbraio1,2,
Natalie Hiscock1,2,3,
Massimo Sacchetti2,
Christian P. Fischer2,3, and
Bente K. Pedersen2,3
1 Skeletal Muscle Research Laboratory, Center for Nutrition Metabolism and Endocrinology, RMIT University, Bundoora, Australia
2 Copenhagen Muscle Research Centre, Copenhagen, Denmark
3 Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
The mechanisms that mediate the tightly controlled production and clearance of glucose during muscular work are unclear, and it has been suggested that an unidentified "work factor" exists that influences the contraction-induced increase in endogenous glucose production (EGP). The cytokine interleukin (IL)-6 is released from skeletal muscle during contraction. Here we show that IL-6 contributes to the contraction-induced increase in EGP. Six men performed 2 h of bicycle exercise on three separate occasions, at a relatively high intensity (HI) or at a low intensity with (LO + IL-6) or without (LO) an infusion of recombinant human IL-6 that matched the circulating concentration of IL-6 seen in HI exercise. The stable isotope 6,6 2H2 glucose was infused to calculate EGP (rate of glucose appearance [Ra]), whole-body glucose disposal (rate of glucose disappearance [Rd]), and metabolic clearance rate (MCR) of glucose. Glucose Ra, Rd, and MCR were higher (P < 0.05) at HI than at LO. Throughout exercise at LO + IL-6, glucose Ra and Rd were higher (P < 0.05) than LO, even though the exercise intensity was identical. In addition, MCR was higher (P < 0.05) at LO + IL-6 than at LO at 90 min. Insulin, glucagon, epinephrine, norepinephrine, cortisol, and growth hormone were identical when comparing LO + IL-6 with LO. These data suggest that IL-6 influences glucose homeostasis during exercise. Our results provide potential new insights into factors that mediate glucose production and disposal and implicates IL-6 in the so-called "work factor."
Address correspondence and reprint requests to Mark A. Febbraio, PhD, Associate Professor, Skeletal Muscle Research Laboratory, Center for Nutrition, Metabolism and Endocrinology, RMIT University, P.O. Box 71, Bundoora 3083, Victoria, Australia. E-mail: mark.febbraio{at}rmit.edu.au
Abbreviations:
EGP, endogenous glucose production; FFA, free fatty acid; HI, high intensity; IL, interleukin; LO, low intensity; MCR, metabolic clearance rate; rh, recombinant human

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. K. Pedersen, T. C. A. Akerstrom, A. R. Nielsen, and C. P. Fischer
Role of myokines in exercise and metabolism
J Appl Physiol,
September 1, 2007;
103(3):
1093 - 1098.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Steensberg, C. Keller, T. Hillig, C. Frosig, J. F. P. Wojtaszewski, B. K. Pedersen, H. Pilegaard, and M. Sander
Nitric oxide production is a proximal signaling event controlling exercise-induced mRNA expression in human skeletal muscle
FASEB J,
September 1, 2007;
21(11):
2683 - 2694.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Febbraio
Exercise and inflammation
J Appl Physiol,
July 1, 2007;
103(1):
376 - 377.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Mooney
COUNTERPOINT: INTERLEUKIN-6 DOES NOT HAVE A BENEFICIAL ROLE IN INSULIN SENSITIVITY AND GLUCOSE HOMEOSTASIS
J Appl Physiol,
February 1, 2007;
102(2):
816 - 818.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. K. Pedersen, M. A. Febbraio, and R. A. Mooney
Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis
J Appl Physiol,
February 1, 2007;
102(2):
814 - 816.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Garma, C. Kobayashi, F. Haddad, G. R. Adams, P. W. Bodell, and K. M. Baldwin
Similar acute molecular responses to equivalent volumes of isometric, lengthening, or shortening mode resistance exercise
J Appl Physiol,
January 1, 2007;
102(1):
135 - 143.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. ALEXANDRAKI, C. PIPERI, C. KALOFOUTIS, J. SINGH, A. ALAVERAS, and A. KALOFOUTIS
Inflammatory Process in Type 2 Diabetes: The Role of Cytokines
Ann. N.Y. Acad. Sci.,
November 1, 2006;
1084(1):
89 - 117.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Weigert, A. M. Hennige, R. Lehmann, K. Brodbeck, F. Baumgartner, M. Schauble, H. U. Haring, and E. D. Schleicher
Direct Cross-talk of Interleukin-6 and Insulin Signal Transduction via Insulin Receptor Substrate-1 in Skeletal Muscle Cells
J. Biol. Chem.,
March 17, 2006;
281(11):
7060 - 7067.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Wong and V. Harber
Lower Excess Postexercise Oxygen Consumption and Altered Growth Hormone and Cortisol Responses to Exercise in Obese Men
J. Clin. Endocrinol. Metab.,
February 1, 2006;
91(2):
678 - 686.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Keller, A. Steensberg, A. K. Hansen, C. P. Fischer, P. Plomgaard, and B. K. Pedersen
Effect of exercise, training, and glycogen availability on IL-6 receptor expression in human skeletal muscle
J Appl Physiol,
December 1, 2005;
99(6):
2075 - 2079.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. P. Kristiansen and T. Mandrup-Poulsen
Interleukin-6 and Diabetes: The Good, the Bad, or the Indifferent?
Diabetes,
December 1, 2005;
54(suppl_2):
S114 - S124.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Bruunsgaard
Physical activity and modulation of systemic low-level inflammation
J. Leukoc. Biol.,
October 1, 2005;
78(4):
819 - 835.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Bach, D. Naon, S. Pich, F. X. Soriano, N. Vega, J. Rieusset, M. Laville, C. Guillet, Y. Boirie, H. Wallberg-Henriksson, et al.
Expression of Mfn2, the Charcot-Marie-Tooth Neuropathy Type 2A Gene, in Human Skeletal Muscle: Effects of Type 2 Diabetes, Obesity, Weight Loss, and the Regulatory Role of Tumor Necrosis Factor {alpha} and Interleukin-6
Diabetes,
September 1, 2005;
54(9):
2685 - 2693.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Weigert, A. M. Hennige, K. Brodbeck, H. U. Haring, and E. D. Schleicher
Interleukin-6 acts as insulin sensitizer on glycogen synthesis in human skeletal muscle cells by phosphorylation of Ser473 of Akt
Am J Physiol Endocrinol Metab,
August 1, 2005;
289(2):
E251 - E257.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Pederson, C. R. Cope, J. M. Schroeder, M. W. Smith, J. M. Irimia, B. L. Thurberg, A. A. DePaoli-Roach, and P. J. Roach
Exercise Capacity of Mice Genetically Lacking Muscle Glycogen Synthase: IN MICE, MUSCLE GLYCOGEN IS NOT ESSENTIAL FOR EXERCISE
J. Biol. Chem.,
April 29, 2005;
280(17):
17260 - 17265.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. W. Petersen and B. K. Pedersen
The anti-inflammatory effect of exercise
J Appl Physiol,
April 1, 2005;
98(4):
1154 - 1162.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Diabetes Association.
|
|
| |
|